Home > Healthcare > Pharmaceuticals > Finished Drug Form > Peptide Therapeutics Market
Peptide Therapeutics Market Trends
- Report ID: GMI5635
- Published Date: May 2023
- Report Format: PDF
Peptide Therapeutics Market Trends
- Researchers have been focusing on developing novel and effective peptide therapies for various diseases, including cancer, given the advantages of peptide therapeutics, such as their ease of synthesis, high target specificity, selectivity, and low toxicity. Peptide therapeutics are considered a promising and effective treatment option for cancer patients due to these advantages over chemotherapy and radiation therapy.
- Additionally, R&D investment includes the development of novel medication delivery systems for peptides. This enables the creation of sustained-release formulations, controlled release, and targeted delivery to specific tissues or cells, enhancing the therapeutic potential of peptides.
- Furthermore, technological improvements have enabled the creation of extensive peptide libraries with diverse sequences. High-throughput screening technologies and next-generation sequencing allow researchers to explore a wide range of peptide candidates for drug development efficiently.
These trends collectively shape the landscape of peptide therapeutics, driving innovation, expanding applications, and enhancing the potential for personalized medicines and targeted treatment options in various disease areas.
Frequently Asked Questions (FAQ) :
Parenteral nutrition industry size was USD 5.7 billion in 2022 and is projected to record USD 11.2 million by 2032 due to the increasing prevalence of chronic diseases and gastrointestinal disorders across the world.
The RTU/standard commercial parenteral nutrition industry held 88.3% revenue share in 2022 and is projected to experience 7% CAGR from 2023-2032 driven by immense popularity among healthcare professionals for reducing the need for on-site compounding and ensuring accurate nutrient delivery.
North America garnered 30% of the parenteral nutrition industry share in 2022 and is anticipated to expand at 7.2% CAGR through 2023 owing to the presence of well-established healthcare infrastructure in the region.
B. Braun Melsungen AG, Baxter International, Inc., Fresenius Kabi AG, OTSUKA HOLDINGS CO., LTD, Amanta Healthcare, Grifols International S.A., ICU Medical, Aculife Healthcare, AbbVie, Inc, and Aguettant are some of the major parenteral nutrition industry players.
Peptide Therapeutics Market Scope
×
Get a free sample of
Peptide Therapeutics Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below